Sonnet BioTherapeutic News

Sonnet BioTherapeutic | 8-K: Current report

Mar 11 19:31

Sonnet BioTherapeutic | 8-K: Current report

Mar 7 05:28

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update

Feb 14 20:37

Sonnet BioTherapeutic | 10-Q: Quarterly report

Feb 14 20:31

Sonnet BioTherapeutic | 8-K: Current report

Feb 2 05:23

Sonnet BioTherapeutic | 8-K: Current report

Jan 30 05:21

Sonnet BioTherapeutic | EFFECT: Others

Jan 5 13:00

Sonnet BioTherapeutic | CORRESP: CORRESP

Jan 4 00:43

Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(6.5%)

Jan 2 13:00

Sonnet BioTherapeutic | UPLOAD: Others

Dec 30, 2023 00:43

Sonnet BioTherapeutic | 8-K: Current report

Dec 27, 2023 13:00

Sonnet BioTherapeutic | S-3: Registration statement for specified transactions by certain issuers

Dec 23, 2023 05:31

Sonnet BioTherapeutic | 8-K: Current report

Dec 16, 2023 05:30

Sonnet BioTherapeutic | 8-K: Current report

Dec 15, 2023 06:03

Sonnet BioTherapeutic: FY2023 Annual Report

Dec 15, 2023 06:02

Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(7.6%)

Nov 18, 2023 00:32

Sonnet BioTherapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John Markey(6.4%)

Nov 7, 2023 00:35

Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Director Rao Raghu

Oct 28, 2023 08:00

Sonnet BioTherapeutic | 4: Statement of changes in beneficial ownership of securities-Officer Mohan Pankaj

Oct 28, 2023 08:00

Sonnet BioTherapeutic | 424B4: Prospectus

Oct 26, 2023 21:00